Skip to main content
. 2001 Nov;45(11):3148–3155. doi: 10.1128/AAC.45.11.3148-3155.2001

TABLE 2.

Etiologies of renal failure and details of CRRT

Patient Etiology of renal failurea Urine output/ 24 h (ml)b Type of CRRT Blood flow rate (ml/min)b Dialysis rate (ml/h)bcd Ultrafiltration rate (ml/min)bd Concomitant vasoactive drug(s)
1 Ischemic ATN 0 CVVH 150 19 ± 2 Dopamine
2 ATN 2° unknown etiology 134 CVVH 150 9 ± 8 None
3 Hepatorenal syndrome 12 CVVH 150 19 ± 4 Dopamine
4 Sepsis with MODS 155 CVVH 150 15 ± 2 Dopamine, norepinephrine
5 Idiopathic thrombocytopenia purpura 35 CVVH 150 17 ± 12 None
6 Cardiogenic shock 0 CVVHDF 150 957 ± 81 18 ± 2 Dopamine, isoproteranol
7 Sepsis with MODS 29 CVVHDF 150 857 ± 227 20 ± 10 Norepinephrine
8 Ischemic ATN 0 CVVHDF 150 940 ± 28 14 ± 1 Dopamine, norepinephrine
9 ATN 2° unknown etiology 0 CVVHDF 150 954 ± 47 20 ± 4 Epinephrine
10 Rhabdomyolysis 67 CVVHDF 150 970 ± 161 23 ± 7 None
11 ATN 2° sepsis with MODS 43 CVVHDF 150 1,000 ± 0 13 ± 2 Dopamine, norepinephrine
12 Cardiogenic shock 0 CVVHDF 150 1,020 ± 26 14 ± 2 Dopamine, epinephrine
a

ATN, acute tubular necrosis; 2°, secondary; MODS, multiple-organ dysfunction syndrome. 

b

During time of pharmacokinetic sampling. 

c

Applicable only to patients receiving CVVHDF. 

d

Rates shown as means ± standard deviations.